Nirmatrelvir Use during the Omicron Surge. Reply

Ronen Arbel; Yael Wolff Sagy; Ariel Hammerman

doi:10.1056/NEJMc2213868

Nirmatrelvir Use during the Omicron Surge. Reply

Ronen Arbel, Yael Wolff Sagy, Ariel Hammerman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2480-2481
Number of pages	2
Journal	The New England journal of medicine
Volume	387
Issue number	26
DOIs	https://doi.org/10.1056/NEJMc2213868
State	Published - 29 Dec 2022
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc2213868

Cite this

@article{90b3c8b0c4fc41e9b066cce4a922d359,

title = "Nirmatrelvir Use during the Omicron Surge. Reply",

author = "Ronen Arbel and {Wolff Sagy}, Yael and Ariel Hammerman",

year = "2022",

month = dec,

day = "29",

doi = "10.1056/NEJMc2213868",

language = "English",

volume = "387",

pages = "2480--2481",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "26",

}

TY - JOUR

T1 - Nirmatrelvir Use during the Omicron Surge. Reply

AU - Arbel, Ronen

AU - Wolff Sagy, Yael

AU - Hammerman, Ariel

PY - 2022/12/29

Y1 - 2022/12/29

UR - http://www.scopus.com/inward/record.url?scp=85145023990&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2213868

DO - 10.1056/NEJMc2213868

M3 - Letter

C2 - 36577109

AN - SCOPUS:85145023990

SN - 0028-4793

VL - 387

SP - 2480

EP - 2481

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 26

ER -

Nirmatrelvir Use during the Omicron Surge. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this